IPO
NEUTRALIP Group Plc Announces Holding Change
The asset manager has disclosed a change in its major shareholding structure.
IP Group
57.75GBX
1.32%
Market Cap
510.20M
Volume
192.48k
5% of avg
P/E Ratio
727.81
EPS (TTM)
0.08
Beta
1.38
Day Range
56.50p - 57.80p
52 Week Range
34.35p57.75p66.16p
57.75p
Upcoming Events
IPO
NEUTRALIP Group Announces Chair Succession Plan
The prominent investment firm announces its Chair will retire at the next AGM, kicking off a succession planning process.
IPO
NEUTRALPulmocide terminates Phase 3 study for Opelconazole
The biopharmaceutical company Pulmocide has announced the termination of its Opera-T Phase 3 study with opelconazole in refractory Invasive Pulmonary Aspergillosis.
IPO
NEUTRALIP Group Plc Announces Holding(s) in Company
The asset management firm has disclosed changes to its major shareholdings in IP Group Plc.
IPO
NEUTRALIP Group Plc Announces Change in Shareholding
The investment firm has disclosed a change in its shareholding in IP Group Plc.
IPO
NEUTRALIP Group Plc Announces Change in Shareholding
The asset management firm has announced a change in shareholding, with BlackRock, Inc. increasing its stake in the company.
IPO
NEUTRALIP Group Plc Announces Holding(s) in Company
The financial services firm has disclosed a change in its shareholding position in IP Group Plc.
IPO
NEUTRALIP Group Plc Announces Change in Shareholding
The financial services firm has disclosed a change in its shareholding structure.
IPO
NEUTRALIP Group Completes £75m Share Buyback Programme
The asset management firm has successfully completed a £75m share buyback programme.